Cirmtuzumab
Monoclonal antibody / From Wikipedia, the free encyclopedia
Cirmtuzumab (also UC-961) is an anti-ROR1 humanised monoclonal antibody.[1][2]
Quick Facts Monoclonal antibody, Type ...
Monoclonal antibody | |
---|---|
Type | ? |
Source | Humanized |
Target | ROR1 |
Clinical data | |
Other names | UC-961 |
Legal status | |
Legal status |
|
Identifiers | |
CAS Number | |
UNII |
Close
It is an experimental drug in early-stage clinical trials for various cancers including chronic lymphocytic leukemia (CLL).[3][4]